Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Harris declinations: A landmark FCPA case?

Jaclyn Jaeger | September 23, 2016

The SEC said this month it will not be taking any action against Harris Corporation following the completion of its investigation into potential violations of the U.S. Foreign Corrupt Practices Act, even as it brought charges against one of the company’s former executives for making bribery payments to Chinese government officials to obtain or retain business.

As Compliance Week previously reported, Harris—a communications company, defense contractor, and information technology services provider—completed its acquisition of Carefx and its subsidiaries, including its China subsidiary, Carefx China in 2011. Following the closing, the company said it “became aware that certain entertainment, travel and other expenses in connection with the Carefx China operations may have been incurred or recorded improperly.”

“In response, we initiated an internal...

Buy this article for $49, or subscribe to Compliance Week for a month at $149 and get unlimited article access for 30 days.